Cognition Therapeutics, Inc. (CGTX) Financials

CGTX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 36.1 million 6.2 million
Dec. 31, 2025 48.4 million 14.1 million
Sept. 30, 2025 43.4 million 6.9 million
June 30, 2025 19.6 million 12.6 million

CGTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -5.5 million 330000
Dec. 31, 2025 -3.4 million 358000
Sept. 30, 2025 -5.7 million 522000
June 30, 2025 -5.6 million 621000

CGTX Net Income

No data available :(

CGTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 31.1 million - 176000
Dec. 31, 2025 37.0 million - 195000
Sept. 30, 2025 39.8 million - 212000
June 30, 2025 10.7 million - 427000

CGTX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 89.2 million
Dec. 31, 2025 88.9 million
Sept. 30, 2025 78.0 million
June 30, 2025 63.7 million

CGTX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 6.1 million 2.7 million -
Dec. 31, 2025 - 11.1 million 2.5 million -
Sept. 30, 2025 - 3.8 million 2.6 million -
June 30, 2025 - 11.5 million 2.5 million -

CGTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 68000
Dec. 31, 2025 - 61000
Sept. 30, 2025 - 61000
June 30, 2025 - 61000

CGTX

Price: $0.92

52 week price:
0.43
3.83

Earnings Per Share: -0.23 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 239600

Market Capitalization: 86.1 million

Links: